Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • rozitaa
    Member
    • Jun 2013
    • 51

    How cufflinks works?

    Hi,

    I have different RNA-seq samples which I want to compare them with each other. I am using cufflinks to compare the transcription level of each gene.

    I am getting different number of total genes per sample. I was expecting the output of cufflinks would be all genes in the ref annotation file and FPKM shows the relevant abundance of appearance of each transcript (some number for those which exist and zero for those that not). As far as I know, "cufflinks has values for all provided transcripts". If I am right, it means only those that are exist in my sequencing data. I am also, getting zero for some of the FPKM. So I cannot conclude the zeros with the mentioned phrase.

    I cannot understand why these are happening and how I can interpret and compare the result. Generally, I want to have an overview of how cufflinks works. I have read cufflinks paper but it was hard for me to hunt answers of these question out of it.

    Any comments about it would be so helpful.

    Thanks
  • seqlearning
    Junior Member
    • Sep 2013
    • 2

    #2
    Originally posted by rozitaa View Post
    Hi,

    I have different RNA-seq samples which I want to compare them with each other. I am using cufflinks to compare the transcription level of each gene.

    I am getting different number of total genes per sample. I was expecting the output of cufflinks would be all genes in the ref annotation file and FPKM shows the relevant abundance of appearance of each transcript (some number for those which exist and zero for those that not). As far as I know, "cufflinks has values for all provided transcripts". If I am right, it means only those that are exist in my sequencing data. I am also, getting zero for some of the FPKM. So I cannot conclude the zeros with the mentioned phrase.

    I cannot understand why these are happening and how I can interpret and compare the result. Generally, I want to have an overview of how cufflinks works. I have read cufflinks paper but it was hard for me to hunt answers of these question out of it.

    Any comments about it would be so helpful.

    Thanks
    Same here.
    I asked my data mapping to a GTF with ~70 genes. Then I used cufflinks to deal with the mapped results, found only about 10 genes with non-zero FPKM.

    Comment

    • liweixie
      Member
      • Oct 2013
      • 21

      #3
      did you have reference gtf file for cufflinks.

      Comment

      • rozitaa
        Member
        • Jun 2013
        • 51

        #4
        Thanks, I found new gtf and fasta reference file and I think the whole problem caused because of the reference files!

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        30 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        213 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        79 views
        0 reactions
        Last Post SEQadmin2  
        Working...